Serial Number | 88110392 |
Word Mark | GALAPAGOS |
Filing Date | Monday, September 10, 2018 |
Status | 700 - REGISTERED |
Status Date | Tuesday, October 22, 2019 |
Registration Number | 5888518 |
Registration Date | Tuesday, October 22, 2019 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 6, 2019 |
Goods and Services | pharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; biopharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes |
Goods and Services | medical services; medical and pharmaceutical advisory and consultancy services; gene bank services |
Goods and Services | medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate same via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; and gene bank services for research purposes |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, September 17, 2018 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, September 17, 2018 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, September 17, 2018 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Galapagos N.V. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Mechelen BE-2800 BE |
Party Name | Galapagos N.V. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Mechelen BE-2800 BE |
Party Name | Galapagos N.V. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Mechelen BE-2800 BE |
Event Date | Event Description |
Tuesday, October 22, 2019 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, August 6, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 6, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, July 17, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, July 2, 2019 | ELECTRONIC RECORD REVIEW COMPLETE |
Friday, June 28, 2019 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Monday, June 24, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, June 10, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, June 10, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, June 5, 2019 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Monday, May 27, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, May 27, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, May 27, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, January 8, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, January 8, 2019 | NON-FINAL ACTION E-MAILED |
Tuesday, January 8, 2019 | NON-FINAL ACTION WRITTEN |
Wednesday, December 19, 2018 | ASSIGNED TO EXAMINER |
Monday, October 22, 2018 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Thursday, October 18, 2018 | ASSIGNED TO LIE |
Tuesday, October 9, 2018 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Monday, September 17, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, September 13, 2018 | NEW APPLICATION ENTERED |